Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-461-500"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"ro"^^xsd:language2
lpv:document identification number	"en.20121023.45.2-461-500"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-461-5622
lpv:speaker	lp:Minodora Cliveti2
lpv:spokenAs	substitute; Delegation to the Euronest Parliamentary Assembly (2012-05-21--2014-06-30)3,3 member; EMPL (2012-05-23--2014-06-30)3,3 member; S&D (2012-05-18--2014-06-30)3,3 substitute; Delegation to the EU-Armenia, EU-Azerbaijan and EU-Georgia Parliamentary Cooperation Committees (2012-05-21--2014-06-30)3,3 substitute; ENVI (2012-05-21--2014-06-30)3,3 unknown; Partidul Social Democrat (2012-05-18--2014-06-30)3,3 member; Delegation to the EU-Moldova Parliamentary Cooperation Committee (2012-05-23--2014-06-30)3,3 substitute; Delegation for relations with Canada (2012-06-20--2014-06-30)3,3 substitute; FEMM (2012-05-21--2014-06-30)3,3
lpv:translated text	"The European Medicines Agency has an important role in providing the best possible scientific advice on any question relating to the evaluation of the quality, the safety and the efficacy of medicinal products for human and veterinary use to the Member States and the institutions. I have noticed that the Agency has improved the scope and methodology of the systematic ex-ante and ex-post controls related to the screening of declaration of interest. It should be commended for its decision to perform a yearly evaluation of its revised policy on declaration of interest. The Agency must keep the discharge authority informed on the implementation of its revised policy and in particular of its systematic ex-ante and ex-post controls on a six-month basis. The agency should introduce in each of its annual activity reports a special section describing the actions taken to prevent and manage conflict of interest. I voted for discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2010."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph